The regime is designed to enable specialist technology companies in five frontier industries to list on the Hong Kong bourse.
October 20, 2022FSDC chairman Laurence Li said Hong Kong we must not allow any "slippage" in its role as an international financial centre, and as a connector to the mainland.
July 19, 2022Finance Secretary Paul Chan announced measures to further reform Hong Kong's listing rules, promote the bond market, and introduce yuan share trading in the city.
February 24, 2022The FSDC says allowing SPACs to list in Hong Kong will help to bolster the city's status as a fundraising hub for the healthcare and biotech sectors.
November 18, 2021Under a new mechanism, listed companies would be able to secure approval for multiple batches of share issuances at once without having to apply for each one individually.
September 5, 2021HKEX will leverage expertise from Hong Kong Science and Technology Parks Corp to help it review biotech listing applications.
September 2, 2021Biotech is the third largest sector by trading value in Taiwan’s stock market. TAIFEX TIP Taiwan BIO Futures can now be offered and sold to US persons.
January 26, 2021Consultation responses suggest that HKEX’s proposal to raise the profit requirement for Main Board listing IPOs will drastically reduce its competitiveness.
January 25, 2021TWSE's board will set a lower market cap requirement and no profitability requirement. TPEx's board will allow companies to apply if they are recommended by two securities firms.
December 4, 2020Pre-revenue biotech companies listed on Hong Kong’s Main Board will be included from 27 December. SSE STAR Market stocks will be included in early 2021.
November 30, 2020